LTRN — Lantern Pharma Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Lantern Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 70.7 | 55.2 | 41.3 | 24 | 10.1 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 72.7 | 58.7 | 43.3 | 25.2 | 10.8 |
| Net Property, Plant And Equipment | 0.216 | 0.096 | 0.28 | 0.287 | 0.107 |
| Other Long Term Assets | |||||
| Total Assets | 74 | 58.8 | 43.6 | 25.6 | 11 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 2.33 | 2.8 | 2.68 | 4.33 | 4.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.38 | 2.8 | 2.74 | 4.38 | 4.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 71.6 | 56 | 40.9 | 21.2 | 6.53 |
| Total Liabilities & Shareholders' Equity | 74 | 58.8 | 43.6 | 25.6 | 11 |
| Total Common Shares Outstanding |